Pitolisant Research Study Seeking Participants
We are currently enrolling for a research study to evaluate the effectiveness of Pitolisant in treating excessive daytime sleepiness in patients with Prader-Willi syndrome, ages 6 to 65 years old. If you are interested to see if you qualify or would like to learn more about this study, please email me (email@example.com) with your name and number and I will contact you directly. All costs related to travel to our clinic will be paid for (including flights, hotels, meals as required), and no out-of-pocket costs to you are expected. I have also attached a document that describes our study in more detail. Sincerely, Sean Ravaei, Clinical Research Coordinator.
Research Study Recruiting PWS Individuals Ages 6 – 65
Harmony Biosciences, a pharmaceutical company dedicated to developing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, has an ongoing Phase 2 clinical trial to evaluate the safety and efficacy of pitolisant, an investigational medicine for excessive daytime sleepiness, behavioral symptoms, and cognitive function in patients with Prader-Willi syndrome. There are 3 trial sites in California that are currently enrolling patients with PWS ages 6-65. If you are interested in participating in this trial or if you’d like to learn more, please contact the site’s coordinator or reach out to Harmony at firstname.lastname@example.org. Thank you!
Rady Children’s Hospital – San Diego
San Diego, California, United States, 92123
Contact: Janelle Celso 858-576-1700 ext 220011 | email@example.com
Principal Investigator: Rakesh Bhattacharjee, MD
Sleep Medicine Specialists of California
San Ramon, California, United States, 94583
Contact: Jenneca Lund 925-415-5353 firstname.lastname@example.org
Principal Investigator: Haramandeep Singh, MD
Santa Monica Clinical Trials
Santa Monica, California, United States, 90404
Contact: Maha Kazim (310) -586-0843 Ext. 103 email@example.com
Principal Investigator: Daniel Norman, MD